News

10/25/19 – BOSTON, MA. – Kim Lewis, a University Distinguished Professor of Biology and Yu Imai, a postdoctoral research associate at LewisÕ lab, hold a petri dish encasing darobactin, a new type of antibiotic that can selectively kill Gram-negative bacteria. Photo by Matthew Modoono/Northeastern University

A New Antibiotic Has Been Hiding in the Gut of a Tiny Worm. It May Be Our Best Weapon Against Drug-resistant Bacteria.

Biology, Biotechnology

After two years of work, a team of researchers led by Kim Lewis, University Distinguished Professor of biology, announced their discovery of darobactin, which can kill resistant microbes known as gram-negative bacteria.

Iron: The Swiss Army Knife for Bacteria

Biochemistry, Bioinformatics, Biology, Biotechnology

Dr. Yunrong Chai and his team discovered new, essential uses for iron in biofilms, the bacterial populations that colonize our bodies, our hospitals, and our world.

Small Pharma: Inside the World of Orphan Diseases, with Alumna Agnes Rafalko

Biology, Biotechnology

Agnes Rafalko got her PhD in proteomics and nanomedicine at Northeastern. She now works as the Chief Scientific Officer of Glycomine, a startup she herself founded that works on drugs for orphan diseases.

David Luzzi, Senior Vice Provost-Research & VP Innovation Campus and Killian O’Driscoll, Director of Projects, NIBRT, sign the BATL-NIBRT Memorandum of Understanding during the Saving Patient Lives: The Role of Biomanufacturing and Bioanalytics symposium held in Building V on Northeastern’s Innovation Campus in Burlington, Massachusetts on Sept. 10, 2019. Photo by Matthew Modoono/Northeastern University

Northeastern Establishes Global Partnership to Improve the Quality of Medicine

Biotechnology, Chemistry and Chemical Biology

Northeastern has joined with a research and training center in Ireland to prepare the next generation of scientists, engineers, and lab technicians to produce high quality drugs for patients around the world.

MS Biotech Student Divya Parikh Honored as 2019 Forbes Under 30 Scholar

Biotechnology

Divya Bharat Parikh, a Northeastern student working towards her MS in Biotechnology, was honored as a Forbes Under 30 Scholar at the 2019 Forbes Under 30 Summit.

They Want to Reveal the Chemistry of Every Enzyme Ever

Biochemistry, Biotechnology, Chemistry and Chemical Biology

Professor of chemistry and chemical biology at Northeastern are using a combination of computational predictions and experimental testing to explore the connection between the chemical make-up of an enzyme and its function.

09/14/15 - BOSTON, MA. - Jared Auclair, Director Biopharmaceutical Analysis Training Laboratory, leads the 2016 APEC Biotherapeutics Centers of Excellence Pilot Training at the Northeastern University Innovation Campus in Burlington on Sept. 14, 2016. Photo by: Matthew Modoono/Northeastern University

Northeastern’s Biopharmaceutical Analysis Training Laboratory offers hands-on sessions for individuals from academic institutions, pharmaceutical companies, and regulatory agencies in manufacturing and regulating drugs. Photo by: Matthew Modoono/Northeastern University

They’re Ensuring Quality Medication Gets to the Patients Who Need It

Biotechnology

The Massachusetts Life Sciences Center is funding BATL's efforts to expand their ability to train people in the pharmaceutical and biotechnology industry in new medications, such as biologics.

Northeastern graduates Francis Nimick, left, and Amanda Stroiney, right, work at the upstart company Outcomes4Me, where they’re developing a mobile app that delivers personalized treatment information to people with breast cancer. Stroiney says that she wouldn’t be working at Outcomes4Me, in Cambridge, Massachusetts, if not for the opportunity to do co-op at the Dana-Farber Cancer Institute as part of the university’s CaNCURE program. Photo by Matthew Modoono/Northeastern University

The Program That's Training the Students who could Transform Cancer Treatment

Behavioral Neuroscience, Biochemistry, Biology, Biotechnology

Northeastern graduates work at the upstart company Outcomes4Me, where they’re developing a mobile app that delivers personalized treatment information to people with breast cancer.

Northeastern graduates Francis Nimick, left, and Amanda Stroiney, right, work at the upstart company Outcomes4Me, where they’re developing a mobile app that delivers personalized treatment information to people with breast cancer. Stroiney says that she wouldn’t be working at Outcomes4Me, in Cambridge, Massachusetts, if not for the opportunity to do co-op at the Dana-Farber Cancer Institute as part of the university’s CaNCURE program. Photo by Matthew Modoono/Northeastern University

The Program That’s Training the Students who could Transform Cancer Treatment

Behavioral Neuroscience, Biochemistry, Biology, Biotechnology

Northeastern graduates work at the upstart company Outcomes4Me, where they’re developing a mobile app that delivers personalized treatment information to people with breast cancer.

Jared Auclair, the director of Northeastern’s BATL, principle investigator and the lead researcher for the grant proposal. Photo by Adam Glanzman/Northeastern University

BATL Awarded $4.3M MLSC Grant to Expand Facilities, Provide Biomanufacturing Trainings

Biochemistry, Biology, Biotechnology

Northeastern's Biopharmaceutical Analysis Training Laboratory was accepted into the 2019 Competitive Capitol Program, enabling the expansion of the campus and improvement to the biomanufacturing industry.

Filter By: